NASDAQ:GRI GRI Bio Q1 2025 Earnings Results & Report $1.12 0.00 (0.00%) Closing price 11/20/2026 03:58 PM EasternExtended Trading$1.18 +0.06 (+5.27%) As of 11/20/2026 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. GRI Bio missed analyst earnings expectations in its Q1 2025 results, released May 15, 2025. The company reported EPS of -$162.40 versus the -$114.24 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateMay 15, 2025TimeBefore Market OpensConference Call8:30 AM ET GRI Bio EPS ResultsActual EPS-$162.40Consensus EPS -$114.24Beat/MissMissed by -$48.16One Year Ago EPSN/AEPS Beat Rate2 of last 5 quartersGRI Bio Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsGRI Bio's Q4 2026 earnings is estimated for Friday, January 29, 2027, based on past reporting schedulesConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) GRI Bio Q1 2025 Earnings FAQ Did GRI Bio beat earnings estimates for Q1 2025? GRI Bio (NASDAQ:GRI) reported earnings of -$162.40 per share for Q1 2025, missing the consensus estimate of -$114.24. The report was announced on Thursday, May 15, 2025. When is GRI Bio's next earnings date? GRI Bio's next earnings date is estimated for Friday, January 29, 2027. MarketBeat tracks confirmed and estimated earnings dates for GRI Bio on the company's earnings history page. GRI Bio Earnings HeadlinesFY2026 Earnings Estimate for GRI Bio Issued By HC WainwrightNovember 20 at 1:42 AM | americanbankingnews.comGRI Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 14, 2026 | marketscreener.comMMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year. | Profits Run (Ad)GRI Bio Stockholders Approve Directors and Equity Plan AmendmentNovember 4, 2026 | tipranks.comGri Bio, Inc. Highlights Immune Modulation and Phase 2A Development Insights in IPF At the 10Th IPF SummitSeptember 30, 2026 | marketscreener.comMGRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF SummitSeptember 28, 2026 | globenewswire.comSee More GRI Bio Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like GRI Bio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GRI Bio and other key companies, straight to your email. Email Address About GRI BioGRI Bio (NASDAQ:GRI) is a clinical-stage biotechnology company developing therapies for inflammatory, fibrotic and autoimmune diseases. Its research focuses on invariant natural killer T (iNKT) cells, a type of immune cell involved in regulating inflammation and immune responses. The company’s lead candidate, GRI-0621, is an oral investigational therapy being developed for idiopathic pulmonary fibrosis, a progressive lung disease. GRI Bio is also advancing other drug candidates that target iNKT-cell biology for potential use in immune-mediated conditions. GRI Bio’s programs are in development, and its candidates have not been approved for commercial use. The company is based in the United States.View GRI Bio ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 11/16 - 11/20If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in LimboAirfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter TestOwens Corning's Stock Slump May Have a Silver Lining for Dividend InvestorsThe Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity StocksHard Drives Were Left for Dead, But Seagate and Western Digital Are Soaring Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.